Literature DB >> 9660452

Clinicopathologic characteristics of the lungs of patients with human T cell lymphotropic virus type 1-associated myelopathy.

K Sugisaki1, T Tsuda, T Kumamoto, S Akizuki.   

Abstract

Lung autopsy specimens were evaluated histologically in the six patients with human T cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy (HAM). The results revealed two histologic changes. First, lymphoid infiltrates were distributed widely in peribronchiolar and perivascular regions, subpleural regions, and the alveolus. Lymphoid infiltrates were also observed in bronchial mucosal glands in relatively large bronchi, in which the acinar epithelium was sometimes degenerated. Second, chronic inflammatory changes, such as smooth muscle hypertrophy, fibrosis, or squamous cell metaplasia, were increased significantly in the membranous bronchioles of HAM patients compared with specimens from lung cancer control patients. Such histologic changes were subclinical in most cases, but one case had an abnormal chest shadow, and two cases had recurrent pneumonia. In HAM patients, high levels of HTLV-1-specific cytotoxic T lymphocytes are believed to attack the HTLV-1-bearing cells in the lung, resulting in inflammatory reactions.

Entities:  

Mesh:

Year:  1998        PMID: 9660452     DOI: 10.4269/ajtmh.1998.58.721

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  7 in total

Review 1.  Pulmonary complications in human T-cell lymphotropic virus type 1 carriers with Sjögren's syndrome, three case reports and literature review.

Authors:  Hui Yu; Futoshi Higa; Ichiro Yamadori; Satomi Yara; Yasushi Tanimoto; Shusaku Haranaga; Masao Tateyama; Jiro Fujita; Mitsune Tanimoto; Huiping Li
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

2.  Higher human T-lymphotropic virus type 1 subtype C proviral loads are associated with bronchiectasis in indigenous australians: results of a case-control study.

Authors:  Lloyd Einsiedel; Olivier Cassar; Emma Goeman; Tim Spelman; Virginia Au; Saba Hatami; Sheela Joseph; Antoine Gessain
Journal:  Open Forum Infect Dis       Date:  2014-05-28       Impact factor: 3.835

3.  Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Authors:  Lloyd Einsiedel; Tim Spelman; Emma Goeman; Olivier Cassar; Mick Arundell; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

4.  Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case-control study.

Authors:  Lloyd Einsiedel; Hai Pham; Virginia Au; Saba Hatami; Kim Wilson; Tim Spelman; Hubertus Jersmann
Journal:  ERJ Open Res       Date:  2019-12-02

Review 5.  Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection.

Authors:  Lloyd Einsiedel; Fabian Chiong; Hubertus Jersmann; Graham P Taylor
Journal:  Retrovirology       Date:  2021-01-06       Impact factor: 4.602

6.  Computed tomography with 6-year follow-up demonstrates the evolution of HTLV-1 related lung injuries: A cohort study.

Authors:  Apio Ricardo Nazareth Dias; Waldonio de Brito Vieira; Valéria Marques Ferreira Normando; Karen Margarete Vieira da Silva Franco; Aline Semblano Carreira Falcão; Rita Catarina Medeiros de Sousa; Hellen Thais Fuzii; Luiz Fábio Magno Falcão; Juarez Antônio Simões Quaresma
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

7.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.